Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.

No treatment has been found which reverses long-standing neurological dysfunction in patients with multiple sclerosis (MS). Observations in animal models of MS show that immunoglobulins directed against CNS components promote oligodendroglial proliferation and new myelin synthesis. Preliminary studi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurol Neurosurg Psychiatry
Main Authors: Noseworthy, J H, O'Brien, P C, van Engelen, B G, Rodriguez, M
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 1994
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1016715/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7964842/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.57.suppl.11
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados